US Stocks
/
CytoMed Therapeutics Limited Share Price

CytoMed Therapeutics Limited Share Price

NASDAQ: GDTC
$0.93
-$0.02 (-1.69%) Last updated on 08 Oct, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CytoMed Therapeutics Limited Stock Performance

Open
$0.93
Prev. Close
$0.94
Circuit Range
N/A
Day Range
$0.93 - $0.93
Year Range
$0.74 - $3.56
Volume
100
Average Traded
$0.93

CytoMed Therapeutics Limited Share Price Today

As of 10 October 2026, CytoMed Therapeutics Limited's share price is $0.93. The stock opened at $0.93, compared to its previous close of $0.94. During today's trading session, CytoMed Therapeutics Limited's share price traded between $0.93 and $0.93, with an average price of $0.93. Over the past 52 weeks, the stock has recorded a high of $3.56 and a low of $0.74. In terms of performance, CytoMed Therapeutics Limited's share price has declined by 4.54% over the last six months and is down 58.89% on a year-on-year basis.

CytoMed Therapeutics Limited Share Price Chart

$0.93$0.93
L
Show Current Price
H

CytoMed Therapeutics Limited Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$250.00M
Return On Equity (TTM)
N/A
Profit Margin
-1244.00%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

CytoMed Therapeutics Limited Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.05$0.25
Net Profit-$3.13-$1.86-$3.11
Net Profit MarginN/A-3720.00%-1244.00%
Income ChangeN/A40.58%-67.20%

About CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

CytoMed Therapeutics Limited Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.86
$0.93
+1.65%
Sep 2026
$0.81
$0.91
-4.71%
Aug 2026
$0.89
$0.95
+0.53%
Jul 2026
$0.99
$0.95
-10.38%
Jun 2026
$1.14
$1.06
-10.17%
May 2026
$0.99
$1.18
+21.78%
Apr 2026
$1.00
$0.97
-3.49%
Mar 2026
$1.04
$1.00
-3.46%
Feb 2026
$1.14
$1.04
+30.00%
Jan 2026
$1.31
$0.80
-41.18%
Dec 2025
$1.96
$1.36
-29.17%
Nov 2025
$1.94
$1.92
-14.67%

GDTC Share Price FAQs

What is CytoMed Therapeutics Limited share price today?

chevron-up
CytoMed Therapeutics Limited share price today is $0.93 as on October 8, 2026 at 1:27 am IST.

What is the 52 week high and 52 week low of CytoMed Therapeutics Limited stock?

chevron-up
The 52 week high of CytoMed Therapeutics Limited stock is $3.56, while the 52 week low is $0.74 as of 8 Oct '26.

What is the 5 year returns of GDTC?

chevron-up
The 5 year returns of GDTC is -72.39% as on 8 Oct '26.

What is the high & low stock price of GDTC today?

chevron-up
GDTC stock price hit a high of $0.93 and low of $0.93 as of 8 Oct '26.

Can I buy GDTC shares in India?

chevron-up
Yes. You can buy GDTC in India by opening an international trading account.